Splenic Infarction with Aortic Thrombosis in COVID-19

Am J Med Sci. 2021 Jun 20:S0002-9629(21)00238-X. doi: 10.1016/j.amjms.2021.06.007. Online ahead of print.ABSTRACTCoronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic thrombosis, which evolved despite the prophylactic use of low-molecular-weight heparin (LMWH), in a 60-year-old female patient with COVID-19. The patient was treated clinically with a therapeutic dose of LMWH, followed by warfarin, and eventually presented a favorable outcome. We also present a review of the literature regarding SI in patients with COVID-19.PMID:34161825 | PMC:PMC8214812 | DOI:10.1016/j.amjms.2021.06.007
Source: The American Journal of the Medical Sciences - Category: General Medicine Authors: Source Type: research